Literature DB >> 25510634

Gastrointestinal stromal tumor of the adrenal gland:a case report and review of the literature.

Hussam Abou Al-Shaar1, Shrouq Solimanie, Ayman Azzam, Tarek Amin, Ahmed Abu-Zaid.   

Abstract

Gastrointestinal stromal tumors (GISTs) are rare neoplasms of the gastrointestinal (GI) tract. The occurrence of these neoplasms ectopically outside the GI tract is extremely uncommon. Only one case of primary adrenal GIST has been reported in the literature. In this account, we report a second case of primary adrenal GIST in a 34-year-old male who presented with a 5-week history of gradually progressive left flank pain and early satiety. Whole-body positron emission tomography (PET)/computed tomography (CT) scan showed a 14 × 11 cm hypermetabolic (18)fluorodeoxyglucose (FDG)-avid mass lesion involving the left adrenal gland and dorsal part of the left hemi-diaphragm. Biopsy of the lesion revealed tumor cells that are immunoreactive to CD-117 and CD-34 and negative to CD-31, S-100, cytokeratin, desmin, and vimentin, features characteristic of GIST. The patient was given imatinib, which drastically decreased his complaints with almost complete resolution of the tumor on his last follow-up radiographic images. Primary left adrenal GIST is an extremely rare neoplasm and can be confused with GISTs arising from the greater curvature of the stomach. Imatinib therapy is optimal in the management of these tumors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25510634     DOI: 10.1007/s12022-014-9350-7

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  41 in total

1.  Gastrointestinal stromal tumors (GISTs): an imaging perspective.

Authors:  Shahina Bano; Sunil Kumar Puri; Lalendra Upreti; Vikas Chaudhary; Hridesh Kumar Sant; Ranjana Gondal
Journal:  Jpn J Radiol       Date:  2011-12-22       Impact factor: 2.374

2.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

3.  Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

Authors:  Markku Miettinen; Hala Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

Review 4.  Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues.

Authors:  Peter Reichardt; Pancras C W Hogendoorn; Elena Tamborini; Massimo Loda; Alessandro Gronchi; Andrés Poveda; Patrick Schöffski
Journal:  Semin Oncol       Date:  2009-08       Impact factor: 4.929

Review 5.  Gastrointestinal stromal tumors: molecular markers and genetic subtypes.

Authors:  Christine M Barnett; Christopher L Corless; Michael C Heinrich
Journal:  Hematol Oncol Clin North Am       Date:  2013-08-26       Impact factor: 3.722

6.  Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors.

Authors:  Ann W Gramza; Christopher L Corless; Michael C Heinrich
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

7.  Primary gastrointestinal stromal tumors in the omentum and mesentery: CT findings and pathologic correlations.

Authors:  Hyo-Cheol Kim; Jeong Min Lee; Se Hyung Kim; Kyoung Won Kim; Minjin Lee; Young Jun Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2004-06       Impact factor: 3.959

8.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Authors:  Charles D Blanke; Cathryn Rankin; George D Demetri; Christopher W Ryan; Margaret von Mehren; Robert S Benjamin; A Kevin Raymond; Vivien H C Bramwell; Laurence H Baker; Robert G Maki; Michael Tanaka; J Randolph Hecht; Michael C Heinrich; Christopher D M Fletcher; John J Crowley; Ernest C Borden
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 9.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

10.  Gastrointestinal stromal tumors: a review of case reports, diagnosis, treatment, and future directions.

Authors:  Christopher B Tan; Wanqing Zhi; Ghulamullah Shahzad; Paul Mustacchia
Journal:  ISRN Gastroenterol       Date:  2012-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.